Our study is the first to reveal that IL-37 could effectively decrease the productions of pro-inflammatory cytokines TNF-α, IL-6 and IL-1β (Figure 5A-F), whereas the productions of cytokine IL-10 were unaffected in PBMCs of SLE patients (Figure 5G-H). Here, TNF is linked to systemic lupus erythematosus.